Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Prasad Iyer"'
Autor:
Amos Hong Pheng Loh, Min Thura, Abhishek Gupta, Sheng Hui Tan, Kelvin Kam Yew Kuan, Koon Hwee Ang, Khurshid Merchant, Kenneth Tou En Chang, Hui Yi Yon, Yong Chen, Mathew Hern Wang Cheng, Arjandas Mahadev, Matthew Chau Hsien Ng, Michaela Su-Fern Seng, Prasad Iyer, Pei Ling Chia, Shui Yen Soh, Qi Zeng
Publikováno v:
Molecular Therapy: Oncolytics, Vol 30, Iss , Pp 153-166 (2023)
Phosphatase of regenerating liver 3 (PRL3) is a specific tumor antigen overexpressed in a broad range of adult cancer types. However, its physiological expression in pediatric embryonal and mesenchymal tumors and its association with clinical outcome
Externí odkaz:
https://doaj.org/article/de65b776c23d4d7cb7d07c8b6584356a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Acute myeloid leukemia (AML) is clinically and genetically a heterogeneous disease characterized by clonal expansion of abnormal hematopoietic progenitors. Genomic approaches to precision medicine have been implemented to direct targeted therapy for
Externí odkaz:
https://doaj.org/article/13d1dec920d94235a94dd3507d5f6f99
Autor:
Wen Qi Cher, Ragavendra Kalyanasundaram, Mei Yoke Chan, Clement KM. Ho, Prasad Iyer, Rajat Bhattacharyya
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 5, Iss 3, Pp 96-99 (2020)
Profound hyperferritinaemia of >10,000 μg/L has been suggested to be highly specific for the diagnosis of paediatric haemophagocytic lymphohistiocytosis (HLH) in western literature but similar studies are lacking in Asian children. We did a single-c
Externí odkaz:
https://doaj.org/article/01535d19f2524992bb29354703f892a5
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 2, Pp 215-231 (2020)
Abstract The novel coronavirus disease (COVID-19) pandemic has caused an unprecedented worldwide socio-economic and health impact. There is increasing evidence that a combination of inflammation and hypercoagulable state are the main mechanisms of re
Externí odkaz:
https://doaj.org/article/578f145bb59042e8bb4b8eefbc30a024
Autor:
Rachel L. Y. Wong, Megan R. E. Wong, Chik Hong Kuick, Seyed Ehsan Saffari, Meng Kang Wong, Sheng Hui Tan, Khurshid Merchant, Kenneth T. E. Chang, Matan Thangavelu, Giridharan Periyasamy, Zhi Xiong Chen, Prasad Iyer, Enrica E. K. Tan, Shui Yen Soh, N. Gopalakrishna Iyer, Qiao Fan, Amos H. P. Loh
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Neuroblastoma is the commonest extracranial pediatric malignancy. With few recurrent single nucleotide variations (SNVs), mutation-based precision oncology approaches have limited utility, but its frequent and heterogenous copy number variations (CNV
Externí odkaz:
https://doaj.org/article/c94105f2a340474b8a92a8bcd7d1fcc0
Autor:
Prasad Iyer, Wee Meng Han, Jasly YS Koo, Yan Yin Lim, Chengsi Ong, Jasper WK Tong, Mei Yoke Chan
Publikováno v:
BMJ Open Quality, Vol 10, Iss 1 (2021)
Poor nutritional status in children with cancer can impact treatment outcomes and mortality. Nutrition screening is a simple yet effective approach to identify malnutrition risk for early intervention. We aim to improve the identification of children
Externí odkaz:
https://doaj.org/article/f702dfa7882248d09336e425eefb7334
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 1, Iss 4, Pp 93-95 (2016)
Externí odkaz:
https://doaj.org/article/764a9355be63426e9e2325f57ee3dce4
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 2, Iss 2, p S11 (2017)
Externí odkaz:
https://doaj.org/article/5d294ac99003409cb46aa106b41d834b
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 2, Iss 1, Pp 12-13 (2017)
Acute undifferentiated leukaemias are rare and can be difficult to treat. Historically due to confusion in nomenclature and the lack of clarity in defining these rare leukaemias there is paucity of data and reports on outcomes for this small group. W
Externí odkaz:
https://doaj.org/article/65568fcc741749669f4dc9abd6e01265
Autor:
Jamil Jasin, He Tong Ng, Indriyati Atmosukarto, Prasad Iyer, Faiezin Osman, Peng Yu Kelly Wong, Ching Yee Pua, Wean Sin Cheow
Publikováno v:
Education and Information Technologies.